Adicet Bio ACET
NASDAQ ACET
$9.51 -0.03 (-0.37%)
As of: Sep 10, 2026 · 2:52 PM EDT

Adicet Bio (ACET) Deferred Taxes (2019 - 2020)

Adicet Bio (ACET) posted Deferred Taxes of $519000.0 for Q4 2020, up 1721.88% on a QoQ basis from -$32000.0 in Q3 2020, and up 1502.7% year-over-year from $32382.8 in Q1 2020.

Analysis

Adicet Bio (ACET) Deferred Taxes (2019 - 2020) Analysis & Trends

Adicet Bio has reported Deferred Taxes for 2 years, with the latest figure at $519000.0 in Q4 2020.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - -
3 Iovance Biotherapeutics 3.64 Bn 3.35 Bn 55.72 Mn -1.37 Mn
4 Legend Biotech 3.54 Bn 2.58 Bn 251.50 Mn -
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn 1.80 Mn
6 Beam Therapeutics 2.53 Bn 2.53 Bn - -
7 Precigen 2.40 Bn 2.40 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.15 Bn 1.36 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Adicet Bio 102.08 Mn -16.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 519,000.00
Sep 30, 2020 -32,000.00
Dec 31, 2019 -37,000.00